Expedition Inspiration raises funds for breast cancer research through locally and nationally organized events and promotions. Every effort is made to partner with local cancer research hospitals so that a portion of the funds from our events can granted to research in the sponsoring community. Funds not restricted in this manner are allocated to projects throughout the United States that are deemed by our Medical Advisory Board to have the most significance in the etiology, prevention, diagnosis, and treatment of breast cancer.

Expedition Inspiration BREAST CANCER SYMPOSIUMS - conducted annually, eminent breast cancer scientists participate in a forum to foster the accelerated exchange of ideas in the field of breast cancer research.
$350,000

FRED HUTCHINSON CANCER RESEARCH CENTER - scrutinizing societal shifts involving diet, exercise and environmental changes that may account for increase in breast cancer incidence.
$25,000

THE WISTAR INSTITUTE - research to isolate human genes associated with the process of metastatic breast cancer as well as continued study into the function of the BRCA 1 gene.
$30,000

UCLA/JONSSON COMPREHENSIVE CANCER CENTER - studies as to whether a moderate intensity exercise program can decrease estrogen levels in premenopausal women at high risk for breast cancer.
$10,000

UNIVERSITY OF PENNSYLVANIA CANCER CENTER - phase I trial with TALL-104 cells in-patients with metastatic breast cancer.
$10,000

DUKE COMPREHENSIVE CANCER CENTER - Immunotherapy of breast cancer using autologous Dendritic cells pulsed with tumor Antigen.
$20,000

DANA FARBER CANCER INSTITUTE - DONALD KUFE, MD - Trial using MUC1 gene in a phase I/II test to measure the safety of this vaccine in 18 women with metastatic breast cancer.
$10,000 ($7,500 granted in 2000 for the same study.)

UNIVERSITY OF WISCONSIN MEDICAL CENTER - studies of a newly discovered natural substance (B-Lapachone derivatives) that kills metastatic breast cancer cells without toxicity to surrounding healthy cells.
$10,000

FRED HUTCHINSON CANCER RESEARCH CENTER - molecular determinants of acquired and intrinsic drug resistance in breast cancer to increase efficacy of adjuvant drug therapies.
$18,000

USC / KENNETH NORRIS COMPREHENSIVE CANCER CENTER - pilot study on the utility of preoperative chemotherapy for locally advanced breast cancer using the promising new agent Paclitaxel.
$31,100

UCLA/JONSSON COMPREHENSIVE CANCER CENTER - research on whether a change in the composition of fat in the diet, not just the quantity of fat intake, can slow or halt the growth of breast tumors.
$21,100

JULIE R. GRALOW, MD, UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE - to study the changes in breast tissue that occur in response to the addition of phytoestrogens to the diet of post-menopausal women to determine if plant estrogens can be a safe and effective alternative to estrogen replacement therapy.
$5,000
$18,500 additionally granted in 2000 to support this study.
$12,000  additionally granted in 2001 to support Dr. Gralow
$10,000  additional grants funds in 2002 supporting Dr. Gralow
$8,500  Granted in 2003 supporting Dr. Gralow
$6,500 Granted in 2004 for additional support for Dr. Gralow.
$15,000 Granted in 2005 for continued support of Dr. Gralow
$5,800 Granted for 2006 to continue to support Dr. Gralow
$3,300 Granted in 2007 to continue to support Dr. Gralow

JINGWEN LIU, PH.D., MOUNTAIN STATES MEDICAL RESEARCH INSTITUTE - Oncosatin M (OM) research, a cytokine produced by white blood cells in the immune system which inhibits growth of breast cancer cells by blocking action of certain factors driving the wild growth of cancer cells.
$10,000

MOUNTAIN STATES TUMOR INSTITUTE - clinical research related to monoclonal antibodies, a promising development in the treatment of breast cancer.
$6000

USC / KENNETH NORRIS COMPREHENSIVE CANCER CENTER - detection of metastatic axillary lymph nodes with Positron Emission Tomography to reduce frequency of axillary node dissection and possibility of lymphedema side effect.
$30,000 (50% provided through USC matching funds)

UCLA/JONSSON COMPREHENSIVE CANCER CENTER - clinical trials utilizing new promising developmental therapies for recurring breast cancer to increase chance of long-term survival.
$30,000 (50% provided through UCLA matching funds)

ANNA MARIA LOPEZ, MD, ARIZONA CANCER CENTER - to study the effect of Neuromuscular Integrative Action of (NIA) on the emotional and physical recovery of women with a history of breast cancer.
$20,000

FRED HUTCHINSON CANCER RESEARCH CENTER - the development of community-based high dose chemotherapy programs that can be administered in smaller cancer centers.
$17,000

MOUNTAIN STATES MEDICAL RESEARCH INSTITUTE - seed grant for the study of CD40 expression in breast cancer; involvement in cytotoxicity and immune enhancement that may lead to significantly improved cancer treatments.
$15,000

OLUFUNMILAYO OLOPADE, MD, UNIVERSITY OF CHICAGO SCHOOL OF MEDICINE - assessing the response to treatment of patients with known BRCA1 and BRCA 2 mutations through collaborative work amongst, but not limited to, participants of the 1998 Expedition Inspiration Breast Cancer Symposium. 1998 Symposium Research Award.
$15,000

Helena Chang, MD, Revlon UCLA Breast Center - studies by of biological interventions in breast cancer prevention, diagnosis and treatment.
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center)
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center)
$26,000     Granted in 2001 for continued support of Dr. Chang
$33,000     Granted in 2002 for continued support of Dr. Chang
$18,000     Granted in 2003 for continued support of Dr. Chang.
$23,800     Granted in 2004 for continued support of Dr. Chang
$28,000     Granted in 2005 for continued support of Dr. Chang
$23,100     Granted for 2006 for continued support of Dr. Chang

MOUNTAIN STATES TUMOR INSTITUTE - to support data management of current breast cancer research protocols including bone marrow transplant procedures and the new Southwest Oncology adjuvant protocols.
$4,000
$2,750 granted in 2000 to support further study
$3,300 granted in 2001 to support further study

PEGGY PORTER, MD, FRED HUTCHINSON CANCER RESEARCH CENTER - assessing the viability of CyclinE and p27 as prognostic markers through cooperative research with Karen Antman, M.D. at Columbia Presbyterian and/or Ruth Heimann at the University of Chicago. 1999 Symposium Research Award.
$15,000

DAITOKU SAKAMURO, MD, THE WISTAR INSTITUTE - for research in the area of tumorigenesis pathways including the novel Myc-interacting breast tumor suppressor protein, BIN1. 1999 recipient of EIFBCR's first annual Outstanding Young Researcher Award.
$10,000

TODD WALDMAN, MD, PH.D., THE LOMBARDI CANCER CENTER - for use in the study of somatic cell gene targeting and human tumor suppressor genes to further development of novel anticancer agents.
$10,000

MICHAEL F. PRESS, MD, USC / KENNETH NORRIS COMPREHENSIVE CANCER CENTER - investigating mechanisms for Tumorigenesis in HER-2/neu overexpressing breast cancers.
$50,000 ($25,000 matched by USC / Kenneth Norris Comprehensive Cancer Center)
$50,000 ($25,000 matched by USC/ Kenneth Norris Comprehensive Cancer Center)
$26,000    Granted in 2001 for continued support of Dr. Press.
$33,000   Granted in 2002 for continued support of Dr. Press.
$82,000 Granted in 2003 for continued support of Dr. Press
$23,800 Granted in 2004 for continued support of Dr. Press.
$28,000  Granted in 2005 for continued support of Dr. Press
$23,100 Granted for 2006 for continued support of Dr. Press
$27,000 Granted in 2007 for continued support of Dr. Press

MAUREEN CHUNG, MD/ WOMEN AND INFANTS HOSPITAL, PROVIDENCE, RI Development if RBCG-IL2MUCI Breast cancer Vaccine. 2000 Symposium Outstanding Young Researcher Award.
$25,000

MARC LIPPMAN, MD/ LOMBARDI CANCER CENTER JOHN PARK, MD/ MT. ZION CANCER CENTER A collaborative grant for: Development of Anti-EGRI VIII Immunoliposomes for Tumor Specific Drug Delivery. 2000 Symposium Research Award.
$20,000

GEORGE VANDE WOUDE, PHD/VAN ANDEL RESEARCH INSTITUTE MALCOLM MITCHELL, MD/ KARMANOS CANCER INSTITUTE A collaborative grant for: Development of Breast Cancer Vaccines: New Epitope Identification. 2000 Symposium Research Award.
$20,000

LISA NEWMAN, MD/ KARMANOS CANCER INSTITUTE 2001 Symposium Outstanding Young Researcher Award for: Feasibility of Evaluating Breast Cancer Patients with Nipple Aspirates and Ductal Lavage.
$20,000

Kathleen Grant, MD/ California Pacific Medical Center STEPHANIE JEFFERY. MD/STANFORD UNIVERSITY A collaborative grant for: Comparison of Molecular Markers (Steroid Receptors) in Asian and Caucasian Breast Cancer Patients.
$16,750

Richard M. Neve, PhD/UCSF Comprehensive Cancer Center 2003 Symposium Outstanding Young Research Award for: ESX:an epithelial-specific Ets transcription factor regulating the metastic potential of human breast cancers.
$10,000

Virginia Kaklamani, MD/ Northwestern University 2003 Symposium Outstanding Young Research Award for: Familial Epidemilogic Study of Polymorphisms of the TGF-B Pathway and Familial Breast Cancer Risk.
$10,000

Peter A. Kaufman, MD/Darthmouth-Hitchcock, Norris Cotton Cancer Center
Conducts research through the Molecular Therapeutics Research Program.
$3,500  awarded in 2004 to support Dr. Kaufman
$5,000 granted in 2005 for continued support of Dr. Kaufman
$6,100 granted in 2006 for continued support of Dr. Kaufman
$7,125   granted in 2007 for continued support of Dr. Kaurman

N. Lynn Henry, MD, PhD,/University of Michigan
2007 Symposium Outstanding Young Investigator Award for: Pilot Study to Characterize Musculoskeltal Changes with Ultrasonography in Women with Breast Cancer Treated with Aramatase Inhibitors.
$10,000

Vijayakrishna K. Gadi, MD, PhD / University of Washington
2007 Symposium Outstanding Young Investigator Award for Fetal Microchimerism in Normal Human Breast and Breast Cancer
$10,000